ACTEMRA (tocilizumab) Patient Assistance Program
Don’t let the high cost of brand specialty IL-6 receptor inhibitor therapy disrupt your treatment. We help eligible patients access Actemra (tocilizumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Actemra (tocilizumab) is FDA-approved for moderate-to-severe rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis (sJIA), polyarticular juvenile idiopathic arthritis (pJIA), cytokine release syndrome (CRS) from CAR-T therapy, COVID-19 in select hospitalized adults, and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Available as IV infusion and SC injection.
- Without assistance, Actemra costs commonly run approximately $3,500–$5,500 per monthly dose, with annual costs commonly $45,000–$70,000+.
- Through AffordMyPrescriptions, qualifying patients can access Actemra for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Tofidence and Tyenne are FDA-approved tocilizumab biosimilars now available at lower cost. Other IL-6 pathway agents include sarilumab (Kevzara, anti-IL-6R SC every 2 weeks).
What Is Actemra Prescription Assistance Program?
The Actemra Prescription Assistance Program is a manufacturer-sponsored initiative that provides Actemra at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for RA, GCA, JIA, and other approved indications in patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, rheumatology coordination, prior-authorization documentation, infusion/specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing infusion or refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Actemra costs roughly $3,500–$5,500 per month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$5,200 | Save ~$5,130/mo |
| CVS Pharmacy | ~$5,500 | Save ~$5,430/mo |
| Walmart | ~$3,800 | Save ~$3,730/mo |
| Costco | ~$3,700 | Save ~$3,630/mo |
Biosimilar (Tofidence/Tyenne) | ~$2,500 | Biosimilar — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Actemra Prescription Program?
The Patient Assistance Program is free to apply for and provides Actemra at no medication cost if approved. Our $69.95/month service covers full advocacy. With tocilizumab biosimilars (Tofidence, Tyenne) now available at lower cost, we’ll help your prescriber determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Actemra:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,500–$5,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Actemra assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Actemra Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Actemra:
Actemra (tocilizumab) is a humanized monoclonal antibody that binds and blocks the interleukin-6 (IL-6) receptor — both soluble and membrane-bound forms. By blocking IL-6 signaling, Actemra interrupts a key driver of inflammation in RA, giant cell arteritis, JIA, and several other immune-mediated conditions.
How Actemra Works:
Interleukin-6 (IL-6) is a cytokine that drives chronic inflammation and immune activity, contributing to conditions like RA, giant cell arteritis, and severe COVID-19. Tocilizumab blocks this process by binding to both soluble and membrane-bound IL-6 receptors. This blockade reduces joint inflammation, normalizes lab markers like CRP and ESR, and improves immune-mediated symptoms. It is also highly effective for treating CAR-T cytokine release syndrome and offers steroid-sparing benefits.
Form and use:
This medication is available in two forms: Actemra IV and Actemra SC. The IV version uses weight-based dosing administered every 4 weeks for RA, or as single doses for CRS and COVID-19. The SC version is a 162 mg injection given weekly or every two weeks and can be self-administered at home. Patients are required to undergo tuberculosis (TB) and hepatitis screening before starting the treatment.
Generic availability:
Substantially lower-cost FDA-approved biosimilars, such as Tofidence and Tyenne, are now available in the U.S. as alternatives to brand-name Actemra. These biosimilars help many patients access the treatment at a much lower out-of-pocket cost. Another related medication in the IL-6 pathway is sarilumab (Kevzara), which is administered subcutaneously every 2 weeks.
Warnings:
The medication carries a Boxed Warning for serious infections, including sepsis, invasive fungal infections, and TB reactivation. It also poses a risk for gastrointestinal perforation, particularly in patients with a history of diverticulitis. Other concerns include laboratory abnormalities like neutropenia and elevated LFTs, demyelinating disease, and hypersensitivity reactions. Patients must also avoid live vaccines while on this therapy.
FAQ (Frequently Asked Questions)
How Much Does Actemra Cost Without Insurance?
Actemra costs approximately $3,500–$5,500 per month. Tocilizumab biosimilars (Tofidence, Tyenne) cost less. Through AffordMyPrescriptions, qualifying patients receive Actemra at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Are Tocilizumab Biosimilars The Same As Actemra?
Yes, clinically. The FDA approves biosimilars only after demonstrating no clinically meaningful differences from the reference product (Actemra). Tofidence and Tyenne are FDA-approved tocilizumab biosimilars with the same indications and similar dosing, at substantially lower cost. Most rheumatologists are comfortable prescribing tocilizumab biosimilars.
How Quickly Will Actemra Work?
For RA, many patients see clinical improvement within 2–4 weeks. For giant cell arteritis, IL-6 blockade allows rapid corticosteroid tapering and helps prevent flares. For CAR-T cytokine release syndrome and severe COVID-19, IL-6 blockade can produce dramatic improvement within hours to days.
Why Do I Need TB Testing Before Actemra?
IL-6 blockade can mask infection symptoms and reactivate latent tuberculosis. TB screening (PPD or QuantiFERON-Gold) is required before starting. Patients with positive screening need TB prophylaxis. Watch for any new signs of infection — fever and CRP may be blunted on Actemra, so threshold for evaluating infection is low.
Can I Get Actemra Through The PAP If I Have Medicare?
Yes. Medicare Part B (for IV infusions) or Medicare Part D (for SC formulation) beneficiaries can typically qualify. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What About Live Vaccines?
Live vaccines (MMR, varicella, MMRV, intranasal flu, yellow fever) should be avoided while on Actemra. Get any needed live vaccines at least 4 weeks before starting Actemra. Inactivated vaccines (flu, pneumococcal, COVID-19, Tdap, HPV) are recommended and safe.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a tocilizumab biosimilar (Tofidence, Tyenne) at lower cost, sarilumab (Kevzara) with its own PAP, a TNF biosimilar, or another biologic, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Arthritis Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Actemra, our team may be able to help you access assistance programs designed to make brand specialty IL-6 receptor inhibitor therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.